A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany

Celeste Boesjes, Marjolein de Bruin-Weller, Nicolaas P A Zuithoff, Said el Bouhaddani, Inge Haeck, Marijke Kamsteeg, Marie-Louise Schuttelaar, Luca Le Treust, Nick Denholm, Ahmet Akkoc, Simon F Thomsen, Ida Vittrup, Thomas Birkner, Luise Heinrich, Jochen Schmitt, Stephan Weidinger, Thomas Werfel · 2026

Read A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany by Celeste Boesjes, Marjolein de Bruin-Weller, Nicolaas P A Zuithoff, Said el Bouhaddani, Inge Haeck, Marijke Kamsteeg, Marie-Louise Schuttelaar, Luca Le Treust, Nick Denholm, Ahmet Akkoc, Simon F Thomsen, Ida Vittrup, Thomas Birkner, Luise Heinrich, Jochen Schmitt, Stephan Weidinger, Thomas Werfel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216443.txt.

Description

Celeste Boesjes and co-authors present a 2026 real-world study of baricitinib, an oral drug for moderate-to-severe eczema, pooling three national treatment registries from the Netherlands, Denmark, and Germany. Trial results do not always survive contact with ordinary practice, so registry evidence matters.

Across 264 patients followed for sixteen weeks, severity scores improved in all three countries, and about 62 percent of the pooled cohort reached mild disease or better. Benefit appeared in patients both new to biologic drugs and those who had used them before. Itch relief varied much more between countries than doctor-measured severity did. The authors call the drug effective in practice while urging longer follow-up and better targeting of who benefits most.

Catalog record

CREATORCeleste Boesjes, Marjolein de Bruin-Weller, Nicolaas P A Zuithoff, Said el Bouhaddani, Inge Haeck, Marijke Kamsteeg, Marie-Louise Schuttelaar, Luca Le Treust, Nick Denholm, Ahmet Akkoc, Simon F Thomsen, Ida Vittrup, Thomas Birkner, Luise Heinrich, Jochen Schmitt, Stephan Weidinger, Thomas Werfel
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13216443

Browse the full library · About the Tower of Babel